secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCURAY INC (ARAY)
CIK:        0001138723
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0000950170-23-060231
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Accuray Q1 revenue $103.9M (+7.7% YoY), net loss narrows to $3M, reaffirms FY2024 outlook
--------------------------------------------------------------------------------

- Revenue $103.9M (+7.7% YoY); product rev $53.4M (+19.7%), service rev $50.5M (-2.7%).
- GAAP net loss $3.0M ($0.03 diluted loss) vs loss $5.4M ($0.06) prior year; adj EBITDA $6.5M vs $1.9M.
- Gross orders $63.7M (book-to-bill 1.2); order backlog $489M, down 9.2% YoY.
- Cash $77.4M, down $12.5M from Q4 FY2023; reiterated FY2024 financial guidance.
- Operational highlights: FDA clearance and CE mark for VitalHold; China NMPA approval for Tomo C.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1138723/000095017023060231/0000950170-23-060231-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1138723/000095017023060231/aray-20231107.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-060231

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer